Publishing research using ab108995? Please let us know so that we can cite the reference in this datasheet.
ab108995 has been referenced in 5 publications.
Monica V et al.Dasatinib modulates sensitivity to pemetrexed in malignant pleural mesothelioma cell lines.Oncotarget 7:76577-76589 (2016).
Lund K et al.Slug-dependent upregulation of L1CAM is responsible for the increased invasion potential of pancreatic cancer cells following long-term 5-FU treatment.PLoS One 10:e0123684 (2015).
Allen MD et al.Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging.Cancer Res 74:896-907 (2014).
Matsumoto Y et al.A phase II study of erlotinib monotherapy in pre-treated non-small cell lung cancer without EGFR gene mutation who have never/light smoking history: re-evaluation of EGFR gene status (NEJ006/TCOG0903).Lung Cancer 86:195-200 (2014).
Lee SW et al.Overexpression of thymidylate synthetase confers an independent prognostic indicator in nasopharyngeal carcinoma.Exp Mol Pathol 95:83-90 (2013).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"